Advertisement Cardima raises $5 million in private placement - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cardima raises $5 million in private placement

Cardima, a developer of diagnostic catheters, has completed a private placement of 8.48 million shares of common stock at $0.60 per share to accredited investors. The total gross proceeds were $5.085 millions.

In addition, the company issued to the investors, warrants to purchase 1.28 million shares of common stock at an exercise price of $0.65 per share.

Tony Shum, chairman of Cardima, said: “This transaction strengthens our balance sheet and allows the excellent team of professionals at Cardima to continue to advance our commercialization and regulatory strategies worldwide.”